Battling CLL: Venclexta

Battling CLL: Venclexta

 Pushing the Self-Destruct Button Breakthrough drug Venclexta charged onto the marketplace three months early to battle chronic lymphocytic leukemia. AbbVie’s (North Chicago, IL) and Roche’s (Basel, Switzerland) new therapy gained a quick approval after 80% of...
Orphan Drugs Lead 2015 Approvals

Orphan Drugs Lead 2015 Approvals

Treatment Options Broaden Driven by 19 new orphan approvals, a whopping 45 novel drugs were cleared for the marketplace in 2015. Additionally, new approvals opened up treatment options for Americans with diseases ranging from breast and lung cancers to irritable bowel...

Alphabet Soup: Drug Development Acronyms

ALPHABET SOUP: NEW DRUG APPROVALS Acronyms abound in the world of new drug approvals. Check out our cheat sheet below for help with some of the most common: BLA: Biologic Licensing Application Planning on developing a biologic drug? Would you like to bring it to...

The FDA’s Decidedly Average Year

2013 DECIDEDLY AVERAGE FOR THE FDA The FDA approved 27 new drugs in 2013, down from the 15-year high of 2012 with its 39 approvals. This should not be cause for alarm since 2013 numbers fall in line with the average of 28 over the last five years (FDA.gov). The FDA...